Work

Cardiac Surgery in Patients with Drug Eluting Stents: The Risk of Stopping Clopidogrel

Year: 2007

Type: article

Abstract: Recommendations for the duration of clopidogrel (Plavix ® , Bristol Meyers Squibb, New York, NY) therapy following drug eluting stent (DES) insertion have been subject to recent criticism. Suggested recommendations for the continuation of clopidogrel have been extended to one year following DES insertion. However, patients with a previously inserted DES who now require cardiac surgery are requested to stop clopidogrel perioperatively. The safety of this practice is unclear. We report two cases of elective cardiac surgical intervention after the insertion of DES complicated by perioperative or intraoperative acute coronary ischemia attributed to DES closure.

Source: Clinical medicine Cardiology

DOI: 10.4137/cmc.s340

Authors: Gorav Ailawadi, John A. Kern, Benjamin B. Peeler, Irving L. Kron

Institution: University of Virginia

Language: English

Topic: Antiplatelet Therapy and Cardiovascular Diseases

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W18059347

FWCI: 0.233

Cites: 12

Cited by: 1

Related to: 10